Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8974
Corporate User License Price USD 375
Corporate User License Price INR 26921
Site License Price USD 250
Site License Price INR 17948
Request a Quote

Report Title

ProMIS Neurosciences Inc. (PMN) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

ProMIS Neurosciences Inc. (PMN) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

ProMIS Neurosciences Inc. (PMN) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

ProMIS Neurosciences Inc. (PMN) - Financial and Strategic SWOT Analysis Review



Executive Summary

ProMIS Neurosciences Inc. (PMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ProMIS Neurosciences Inc. (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying low levels of misfolded proteins in the biological samples which helped in generating cerebrospinal fluid screening test for Alzheimer's disease. The company's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto Ontario, Canada.

ProMIS Neurosciences Inc. Key Recent Developments

Sep 14, 2016: ProMIS Neurosciences to Present at CNS Diseases World Summit 2016

Sep 13, 2016: ProMIS Neurosciences announces positive validation of novel antibody therapeutic candidates for Alzheimer's disease

Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results

Jul 29, 2016: ProMIS Neurosciences Announces Results in Two Presentations at the 2016 Alzheimer's Association International Conference

Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1 - About the Company 6

ProMIS Neurosciences Inc. - Key Facts 6

ProMIS Neurosciences Inc. - Key Employees 7

ProMIS Neurosciences Inc. - Key Employee Biographies 8

ProMIS Neurosciences Inc. - Major Products and Services 9

ProMIS Neurosciences Inc. - Pharmaceutical Pipeline Products Data 10

ProMIS Neurosciences Inc., Pipeline Products by Therapy Area 10

ProMIS Neurosciences Inc., Pipeline Products by Development Phase 11

ProMIS Neurosciences Inc. - History 13

ProMIS Neurosciences Inc. - Company Statement 17

ProMIS Neurosciences Inc. - Locations And Subsidiaries 18

Head Office 18

Section 2 - Company Analysis 19

ProMIS Neurosciences Inc. - Business Description 19

ProMIS Neurosciences Inc. - Corporate Strategy 20

ProMIS Neurosciences Inc. - SWOT Analysis 21

SWOT Analysis - Overview 21

ProMIS Neurosciences Inc. - Strengths 21

Strength - Proprietary Technologies 21

Strength - Focused Research and Development 21

ProMIS Neurosciences Inc. - Weaknesses 22

Weakness - Operational Deficit 22

ProMIS Neurosciences Inc. - Opportunities 23

Opportunity - Growing Elderly Population 23

Opportunity - Business Initiatives 23

Opportunity - Product Pipeline 23

ProMIS Neurosciences Inc. - Threats 24

Threat - Government Regulations 24

Threat - Uncertain R&D Outcomes 24

Threat - Intense Competition 24

ProMIS Neurosciences Inc. - Key Competitors 25

Section 3 - Company Financial Ratios 26

Financial Ratios - Capital Market Ratios 26

Financial Ratios - Annual Ratios 27

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 - Company's Lifesciences Financial Deals and Alliances 31

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

ProMIS Neurosciences Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 33

ProMIS Neurosciences Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 34

ProMIS Neurosciences Inc., Recent Deals Summary 35

Section 5 - Company's Recent Developments 36

Sep 14, 2016: ProMIS Neurosciences to Present at CNS Diseases World Summit 2016 36

Sep 13, 2016: ProMIS Neurosciences announces positive validation of novel antibody therapeutic candidates for Alzheimer's disease 37

Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results 38

Jul 29, 2016: ProMIS Neurosciences Announces Results in Two Presentations at the 2016 Alzheimer's Association International Conference 40

Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer 41

Jul 19, 2016: ProMIS Neurosciences announces new program to identify novel ALS disease targets on toxic strains of protein TDP43 42

Jul 15, 2016: ProMIS Neurosciences Announces Retention of Mackie Research Capital as Market Maintenance Service Provider 43

Jul 12, 2016: Promis Neurosciences Provides Executive Chairman's Summary From Annual Meeting Of Shareholders 44

Jun 29, 2016: ProMIS Neurosciences Announces Two Presentations at the 2016 Alzheimer's Association International Conference 45

Jun 02, 2016: ProMIS Neurosciences announces identification of multiple product candidates targeting Alzheimer's disease 46

Section 6 - Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

ProMIS Neurosciences Inc., Pipeline Products by Therapy Area 10

ProMIS Neurosciences Inc., Pipeline Products by Development Phase 11

ProMIS Neurosciences Inc., Performance Chart (2011 - 2015) 28

ProMIS Neurosciences Inc., Ratio Charts 30

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 32

ProMIS Neurosciences Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 33

ProMIS Neurosciences Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 34

List of Tables

ProMIS Neurosciences Inc., Key Facts 6

ProMIS Neurosciences Inc., Key Employees 7

ProMIS Neurosciences Inc., Key Employee Biographies 8

ProMIS Neurosciences Inc., Major Products and Services 9

ProMIS Neurosciences Inc., Number of Pipeline Products by Therapy Area 10

ProMIS Neurosciences Inc., Number of Pipeline Products by Development Stage 11

ProMIS Neurosciences Inc., Pipeline Products By Therapy Area and Development Phase 12

ProMIS Neurosciences Inc., History 13

ProMIS Neurosciences Inc., Key Competitors 25

ProMIS Neurosciences Inc., Ratios based on current share price 26

ProMIS Neurosciences Inc., Annual Ratios 27

ProMIS Neurosciences Inc., Interim Ratios 29

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

ProMIS Neurosciences Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

ProMIS Neurosciences Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 33

ProMIS Neurosciences Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 34

ProMIS Neurosciences Inc., Recent Deals Summary 35

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Predictive Diagnostics, Inc.

Johnson & Johnson

Inova Diagnostics, Inc.

Idexx Laboratories, Inc.

Eli Lilly and Company

DiaSorin S.p.A

Diagnostica Stago, Inc.

Celera Diagnostics (Inactive)


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand